| Schedule of Segment Reporting Information |
The following table summarizes select operating results information for each reportable segment (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma |
|
$ |
20,713 |
|
|
$ |
19,231 |
|
|
$ |
39,058 |
|
|
$ |
36,345 |
|
Interventional Dry Eye |
|
|
2,675 |
|
|
|
333 |
|
|
|
4,028 |
|
|
|
727 |
|
Total |
|
|
23,388 |
|
|
|
19,564 |
|
|
|
43,086 |
|
|
|
37,072 |
|
Cost of goods sold |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma cost of goods sold |
|
|
2,835 |
|
|
|
2,772 |
|
|
|
5,178 |
|
|
|
5,070 |
|
Interventional Glaucoma tariff recovery |
|
|
(1,231 |
) |
|
|
— |
|
|
|
(1,231 |
) |
|
|
— |
|
Interventional Dry Eye cost of goods sold |
|
|
545 |
|
|
|
205 |
|
|
|
922 |
|
|
|
321 |
|
Interventional Dry Eye tariff recovery |
|
|
(135 |
) |
|
|
— |
|
|
|
(135 |
) |
|
|
— |
|
Total cost of goods sold |
|
|
2,014 |
|
|
|
2,977 |
|
|
|
4,734 |
|
|
|
5,391 |
|
Gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
Interventional Glaucoma |
|
|
19,109 |
|
|
|
16,459 |
|
|
|
35,111 |
|
|
|
31,275 |
|
Interventional Dry Eye |
|
|
2,265 |
|
|
|
128 |
|
|
|
3,241 |
|
|
|
406 |
|
Total |
|
|
21,374 |
|
|
|
16,587 |
|
|
|
38,352 |
|
|
|
31,681 |
|
Operating expense |
|
|
(25,262 |
) |
|
|
(28,254 |
) |
|
|
(54,653 |
) |
|
|
(57,207 |
) |
Investment income |
|
|
678 |
|
|
|
1,026 |
|
|
|
1,419 |
|
|
|
2,174 |
|
Interest expense |
|
|
(1,290 |
) |
|
|
(1,284 |
) |
|
|
(2,557 |
) |
|
|
(2,547 |
) |
Other income (expense), net |
|
|
82 |
|
|
|
24 |
|
|
|
53 |
|
|
|
(115 |
) |
Loss before income taxes |
|
$ |
(4,418 |
) |
|
$ |
(11,901 |
) |
|
$ |
(17,386 |
) |
|
$ |
(26,014 |
) |
|